[Purpose] The purpose of this study was to explain the difference in characteristics of exercise limitation factors of patients with chronic obstructive pulmonary disease (COPD) and sequelea of pulmonary tuberculosis (PTB-s) .
INTRODUCTION
Rehabilitation based on exercise training has been demonstrated to improve exercise tolerance and ADL and QOL scores in patients with chronic obstructive pulmonary disease (COPD). In 2006, in a revised version of the Global Initiative for Chronic Obstructive Lung Disease (GOLD), the statement, "COPD is a preventable and treatable disease" was added to its definition 1) . COPD is one condition for which the effectiveness of exercise training is well established.
On the other hand, there have been few studies of pulmonary rehabilitation in patients with restrictive pulmonary disease [2] [3] [4] . In recent years, there has been an increase in research into pulmonary rehabilitation for patients with interstitial pulmonary disease [5] [6] [7] [8] , but there have been few studies on sequelae of pulmonary tuberculosis (PTB-s) [9] [10] [11] [12] [13] [14] [15] . Although the incidence of PTB-s is declining, there are still numerous patients undergoing pulmonary rehabilitation programs (PRP), and verification of their effectiveness is essential.
There are differences in etiology between COPD and PTB-s. COPD is considered to be a progressive airflow restriction (obstructive ventilatory i m p a i r m e n t ) r e s u l t i n g f r o m a n a b n o r m a l inflammatory reaction in the whole lungs caused by inhalation of poisonous particles and gaseous substances, while PTB-s can be: a cicatricial restrictive ventilatory impairment caused by the deposition of fibrous connective tissue in lung lesions during the healing process; a mixed v e n t i l a t o r y i m p a i r m e n t r e s u l t i n g f r o m compensatory emphysematous changes; or a restrictive ventilatory impairment resulting from a thoracic cage deformity after an operation. Although the etiologies of the two diseases are completely different, reductions in exercise tolerance and ADL and QOL scores caused by respiratory symptoms, especially increased feelings of dyspnea during exercise, are observed in both COPD and PTB-s.
The evaluation of exercise limitation factors, which is now conducted clinically, is mainly based on the assessment of oxygenation ability, but the comprehensive assessment of ventilatory and circulatory ability has not been sufficiently undertaken and characteristics of exercise limitation factors in diseases such as COPD and PTB-s have rarely been investigated. However, the development of an individual training program according to the characteristics of each patient is essential for optimal efficacy, and therefore contributory factors such as oxygenation, ventilatory, circulatory, and metabolic abilities may need to be taken into account.
In this study, the presence or absence of diseasespecific characteristics in relation to exercise limitation factors was investigated by comparing indices of the cardiopulmonary exercise test (CPET) patients with COPD or PTB-s. The validity of applying a standard COPD respiratory rehabilitation program to patients with restrictive pulmonary diseases has recently been discussed, so we also examined the characteristics of training programs for patients with obstructive and restrictive pulmonary diseases.
SUBJECTS AND METHODS

Subjects
The subjects were 29 patients with COPD (28 males and 1 female) and 8 patients with PTB-s (5 males and 3 females) who were participating in PRP in a hospital specialising in respiratory diseases. Patients with significant physical dysfunction, serious complications separate from the underlying disease, or unable to understand the objective of the study were excluded.
Methods
CPET was conducted using a respiratory metabolism measuring device (RM300i, Minato M e d i c a l S c i e n c e , O s a k a , J a p a n ) w i t h a n electronically braked cycle ergometer and simultaneous breath-by-breath analysis of expired gas. During CPET, heart rate, rhythm and STs e g m e n t c h a n g e w e r e r e c o r d e d u s i n g a n electrocardiograph (CardiofaxA PEC-1320, Nihon Kohden, Tokyo, Japan). CPET consisted of a steady-state resting period and a 1-minute warm-up of unloaded pedaling followed by a ramp protocol in which the work rate was increased at 1-minute intervals by increments of 10 W. All CPET were terminated at the point of symptom limitation (peak exercise). Parameters measured were oxygen uptake at peak exercise (peak V
, and oxygen pulse (peak O 2 pulse). In addition, maximal voluntary ventilation (MVV) was measured twice with a spirometer (Autospiro AS502, Minato Medical Science, Osaka, Japan) and the better value was divided by peak V • E to obtain a dyspnea index. Percutaneous oxygen saturation (SpO 2 ) was measured with an oximeter (Signal extraction pulse oximeter, RDS-1, Masimo; Tokyo, Japan) and the difference between SpO 2 at peak exercise and SpO 2 at rest was divided by SpO 2 at rest to give the rate-of-change, ∆SpO 2 . Subjects rated the magnitude of their perceived breathing and leg discomfort at rest, every minute during exercise, and at peak exercise by pointing to a 10-point Borg scale.
Upon exercise cessation, subjects were asked to describe the main reason for stopping exercise: for example, breathing discomfort, leg discomfort, both breathing and leg discomfort. If the heart rate reached 85% of its predicted maximum (220 -age), an electrocardiogram abnormality was found, or SpO 2 became 85% or less, measurement was discontinued.
Muscle volume ratio (% muscle volume) was measured with a body composition measuring instrument (Body Planner EX/P DF830, Yamato Scale, Akashi, Japan). To assess respiratory muscle power, maximal inspiratory pressure (MIP) measured as inspiratory muscle power, and maximal expiratory pressure (MEP) measured as expiratory muscle power were each determined twice with an oral manometer (Vitalopower KH-101, Chest, Tokyo, Japan), and the better values were selected. A six-minute walking test (6MWT) and an incremental shuttle walking test (ISWT) were carried out as field walking tests for the evaluation of exercise tolerance. The 6MWT was conducted according to Steele's procedure: patients walked back and forth along a 30 m interval in the hallway of a training room. Patients were instructed to walk for as long as possible within the limited time and the distance they walked was measured.
In ISWT, patients were instructed to walk outside marks set at 0.5 m from both ends of a distance of 10 m set on level ground to avoid rapid changes in direction. Walking speed was gradually increased; patients were instructed to walk to regular signal sounds generated from a CD player so as to make this test an incremental exercise test in which walking distance increased by 10 m per minute [starting with 3 times walking of the distance (level 1) and finishing with 14 times (level 12), with a final walking speed of 8.4 km/h] and the total walking distance was finally determined.
The Nagasaki University Respiratory ADL Questionnaire (NRADL) was used for ADL evaluation and total scores were collected.
Age, MRC scale scores, PaO 2 , PaCO 2 , %FVC, FEV 1 . 0 %, and BMI were compared to find differences in characteristics between patients with COPD and patients with PTB-s, while % muscle volume, MIP, MEP, walking distance in the 6MWT, walking distance in the ISWT, and NRADL scores were compared to examine differences in related items such as muscle function, exercise intolerance, and ADL score using the Student's t-test.
In addition, to investigating the characteristics of movement restriction factors at peak exercise, peak V
MVV, dyspnea index, ∆SpO 2 , Borg scale chest and Borg scale leg at peak exercise, ∆SpO 2 , and peak O 2 pulse were compared using Student's t-test.
SPSS version 11 for Windows was used for statistical analysis, with a statistically significant level of 5% or less. Data are expressed as mean ± standard deviation (SD).
RESULTS
%FVC was significantly lower in PTB-s patients than in COPD patients (p 0.01). FEV 1.0 % was significantly lower in COPD patients than in PTB-s patients (p<0.05). Body mass index (BMI) was significantly lower in PTB-s patients than in COPD patients (p<0.05). There were no significant differences in age, Medical Research Council (MRC) scale scores, PaO 2 , or PaCO 2 between COPD and PTB-s patients (Table 1) .
When comparing values of measurement items, no significant differences were observed between COPD and PTB-s for % muscle volume, MIP, MEP, 6MWT, and ISWT. There were also no significant differences in NRADL scores and peak V • O 2 . Although the diseases themselves are different, exercise tolerance and ADL scores were similar in both patient groups (Table 2) .
In examinations of exercise limitation factors at peak exercise, there was no significant difference between COPD and PTB-s in ∆SpO 2 , which shows oxygenation ability, and no specific exercise limitation factor was recognized. Peak V • E, an index of ventilation, was significantly lower in PTB-s than in COPD (p<0.05) indicating that patients with PTB-s were able to achieve little ventilation volume at peak exercise. Although there was no significant difference in the dyspnea index, an index of breathing reserve, between COPD and PTB-s, there was a tendency for the breathing reserve to be low in COPD but sustained in PTB-s. Although Peak V 2 , which are indices of ventilation efficiency, were high in both COPD and PTB-s, indicating a low ventilation efficiency, no significant differences were observed and the indices were not recognized as specific exercise limitation factors. In the Borg scales for feelings of dyspnea and fatigue in the lower limbs at peak exercise, no significant differences were found between the groups and no characteristic subjective symptoms were observed as exercise limitation factors. The Peak O 2 pulse, an index of circulatory ability, was 6.6 ± 1.8 ml/beat/min in COPD and 4.5 ± 1.4 ml/beat/min in PTB-s (p<0.01), showing that the reaction of the circulatory system to exercise was poor in both groups (Table 3) .
DISCUSSION
In terms of subject characteristics, patients with COPD had significantly lower FEV 1.0 % values than patients with PTB s, while patients with PTB-s had significantly lower %FVC values than patients with COPD. However, as the comparison was between two groups of patients with different types of ventilatory impairment, the differences should be understood as an observation only in this investigation. Although the BMI, an index of nutritional status, was significantly lower in patients with PTB-s than in those with COPD, there were no significant differences between the two groups in other factors such as age, MRC score, PaO 2 , or PaCO 2 , nor were there significant differences between the two groups in indices of muscle strength, physical capability, and ADL as determined by %MV, MIP, MEP, 6MWT, ISWT, and NRADL scores, indicating that the two groups were comparable in terms of overall degree of impairment.
As regards exercise limitation, although NRADL scores were comparatively high, and feelings of difficulty in breathing as judged by MRC scale scores were mild, in both groups, comparison of peak V
• O 2 values with those of similarly aged individuals indicated significantly low systemic endurance in both disease groups. characteristics of exercise limitation factors, subjective symptoms, oxygenation ability, ventilatory ability, and circulatory ability were examined. The tendencies of subjective symptoms have previously been reported to be as follows: feelings of fatigue in the lower limbs are a more usual reason for stopping exercise than feelings of difficulty in breathing in both healthy individuals and patients with mild COPD 16) , and feelings of fatigue in the lower limbs are a more usual reason than other causes for stopping exercise in normal subjects. Regarding subjective symptoms at peak exercise in patients with PTB-s, it has been reported that Borg scale scores for feelings of difficulty in breathing are likely to be higher than scores for feelings of fatigue in the lower limbs 9) . However, in the present study, no significant differences in feelings of difficulty in breathing and feelings of fatigue in the lower limbs at peak exercise were observed between patients with COPD and patients with PTB-s, indicating that subjective symptoms c a n n o t b e c o n s i d e r e d d i s e a s e -s p e c i f i c characteristics of exercise limitation factors.
I n c o n n e c t i o n w i t h d i s e a s e -s p e c i f i c
As far as oxygenation ability is concerned, no significant difference in ∆SpO 2 was observed between the two groups of patients, and no diseasespecific characteristics with a strong ability to induce desaturation by exercise were identified. Oxygenation ability can be considered as a diseasespecific characteristic in both interstitial pulmonary disease and COPD, but comparison of oxygenation ability in patients with COPD and patients with PTB-s in this study indicated that it is unlikely to be a disease-specific characteristic for exercise limitation.
No significant differences in either Peak V 2 , indices of ventilation efficacy, were observed between the two groups of patients, although in both groups the values were lower than in healthy individuals 17, 18) . Thus, it is suggested that ventilation efficacy as a movement restriction factor is not likely to be a disease-specific characteristic.
In relation to breathing reserve, although there was no significant difference in MVV between the two groups, Peak V • E was significantly higher in patients with COPD than in patients with PTB-s at peak exercise, which was reflected in the dyspnea index, another index of breathing reserve. Although there was no significant difference in the dyspnea index between the two groups, the COPD group showed a lower breathing reserve than the PTB-s group, indicating an inadequate breathing reserve. In healthy individials the dyspnea index has been reported to range from 50% to 80%, and the breathing reserve from 20% to 50% 19) ; however, the breathing reserve in patients with COPD has been reported to be reduced due to the influence of dynamic hyperinflation or other factors [20] [21] [22] . In this study, the dyspnea index indicated a breathing reserve in patients with PTB-s similar to that in healthy individuals but the breathing reserve in patients with COPD was low. These results indicate that the difference in breathing reserve between patients with COPD and those with PTB-s might be a disease-specific characteristic of the two groups which could be used as an exercise limitation factor.
As regards circulatory ability, the O 2 pulse, an index of stroke volume, was significantly low at peak exercise in patients with PTB-s and the ability to adjust the output of blood in response to the demands of exercise was low. Since PTB-s generally affects patients longer than COPD, it might be that cardiac loading is gradually increased by respiratory failure. Ferrer noted that the major factor in pulmonary heart disease is pulmonary hypertension 23) , and that gradually developing hypoxemia is more likely to cause contraction of the pulmonary capillary vessels resulting in elevated pulmonary artery pressure in patients with PTB-s than in those with COPD 24, 25) . This is supported by the observations of Kim et al. 26) , who also reported that right ventricular failure is more frequent in patients with PTB-s than in patients with COPD. In the present study, an insufficient increase in stroke volume accompanying insufficient circulatory ability and increased exercise was observed to a greater extent in patients with PTB-s than in patients with COPD. These differences in reaction performances during exercise are considered important disease-specific characteristics for exercise limitation in PTB-s.
Finally, when considering a respiratory rehabilitation program, it is noteworthy that the presence of disease-specific characteristics was indicated in this study, namely breathing reserve in COPD and stroke volume in PTB-s.
A number of reports have demonstrated that dynamic hyperinflation can be suppressed by concomitant pharmacotherapy with tiotropium bromide and salmeterol, and kinesitherapy [27] [28] [29] [30] [31] , and clinical evidence to aid development of a program for improving breathing reserve during exercise in patients with COPD has gradually accumulated. On the other hand, there have been few studies that would assist the establishment of a program aimed at increasing stroke volume during exercise in patients with PTB-s. Studies on the synergistic effects of pharmacotherapy and kinesitherapy on the circulatory system may enable the establishment of a rehabilitation program based on the disease-specific characteristics of PTB-s. In addition, studies of the independent effects of kinesitherapy alone on improvements in ventilatory ability and circulatory ability through the examination of loading, frequency, duration, and kind of exercise may be essential, as well as studies on the synergic effects of kinesitherapy and pharmacotherapy. It is expected that if a specific training method could be established for each segmentalized exercise limitation factor, rehabilitation for patients with respiratory failure could be more effectively conducted.
